Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial

被引:458
作者
Bolland, Mark J. [1 ]
Barber, P. Alan [1 ]
Doughty, Robert N. [1 ]
Mason, Barbara [1 ]
Horne, Anne [1 ]
Ames, Ruth [1 ]
Gamble, Gregory D. [1 ]
Grey, Andrew [1 ]
Reid, Ian R. [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1, New Zealand
来源
BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 336卷 / 7638期
关键词
D O I
10.1136/bmj.39440.525752.BE
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women. Design Randomised, placebo controlled trial. Setting Academic medical centre in an urban setting in New Zealand. Participants 1471 postmenopausal women (mean age 74): 732 were randomised to calcium supplementation and 739 to placebo. Main outcome measures Adverse cardiovascular events over five years: death, sudden death, myocardial infarction, angina, other chest pain, stroke, transient ischaemic attack, and a composite end point of myocardial infarction, stroke, or sudden death. Results Myocardial infarction was more commonly reported in the calcium group than in the placebo group (45 events in 31 women v19 events in 14 women, P=0.01). The composite end point of myocardial infarction, stroke, or sudden death was also more common in the calcium group (101 events in 69 women v 54 events in 42 women, P=0.008). After adjudication myocardial infarction remained more common in the calcium group (24 events in 21 women v 10 events in 10 women, relative risk 2.12, 95% confidence interval 1.01 to 4.47). For the composite end point 61 events were verified in 51 women in the calcium group and 36 events in 35 women in the placebo group (relative risk 1.47, 0.97 to 2.23). When unreported events were added from the national database of hospital admissions in New Zealand the relative risk of myocardial infarction was 1.49 (0.86 to 2.57) and that of the composite end point was 1.21 (0.84 to 1.74). The respective rate ratios were 1.67 (95% confidence intervals 0.98 to 2.87) and 1.43 (1.01 to 2.04); event rates: placebo 16.3/1000 person years, calcium 23.3/1000 person years. For stroke (including unreported events)the relative risk was 1.37 (0.83 to 2.28) and the rate ratio was 1.45 (0.88 to 2.49). Conclusion Calcium supplementation in healthy postmenopausal women is associated with upward trends in cardiovascular event rates. This potentially detrimental effect should be balanced against the likely benefits of calcium on bone. Trial registration Australian Clinical Trials Registry ACTRN 012605000242628.
引用
收藏
页码:262 / 266
页数:9
相关论文
共 33 条
  • [1] Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Alto, P
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    Van de Werf, F
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 959 - 969
  • [2] Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement
    Anavekar, N
    Bais, R
    Carney, S
    Eris, J
    Gallagher, M
    Johnson, D
    Jones, G
    Sikaris, K
    Lonergan, M
    Ludlow, M
    Mackie, J
    Mathew, T
    May, S
    McBride, G
    Meerkin, M
    Peake, M
    Power, D
    Snelling, P
    Voss, D
    Walker, R
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2005, 183 (03) : 138 - +
  • [3] ANGUS RM, 1989, J AM DIET ASSOC, V89, P209
  • [4] Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
    Asmus, HG
    Braun, J
    Krause, R
    Brunkhorst, R
    Holzer, H
    Schulz, W
    Neumayer, HH
    Raggi, P
    Bommer, J
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (08) : 1653 - 1661
  • [5] CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION
    BAMFORD, J
    SANDERCOCK, P
    DENNIS, M
    BURN, J
    WARLOW, C
    [J]. LANCET, 1991, 337 (8756) : 1521 - 1526
  • [6] Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
    Block, G. A.
    Raggi, P.
    Bellasi, A.
    Kooienga, L.
    Spiegel, D. M.
    [J]. KIDNEY INTERNATIONAL, 2007, 71 (05) : 438 - 441
  • [7] Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
    Block, GA
    Spiegel, DM
    Ehrlich, J
    Mehta, R
    Lindbergh, J
    Dreisbach, A
    Raggi, P
    [J]. KIDNEY INTERNATIONAL, 2005, 68 (04) : 1815 - 1824
  • [8] Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781
  • [9] EFFECT OF CALCIUM AND CHOLECALCIFEROL TREATMENT FOR 3 YEARS ON HIP-FRACTURES IN ELDERLY WOMEN
    CHAPUY, MC
    ARLOT, ME
    DELMAS, PD
    MEUNIER, PJ
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6936) : 1081 - 1082
  • [10] Combined calcium and vitamin D3 supplementation in elderly women:: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk:: The Decalyos II study
    Chapuy, MC
    Pamphile, R
    Paris, E
    Kempf, C
    Schlichting, M
    Arnaud, S
    Garnero, P
    Meunier, PJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 (03) : 257 - 264